Your Search Returned 97 tagged news reports
is a leading medical device company that offers a spectrum of high-tech treatments for cardiovascular diseases, diabetes and neurological disorders...If the deal clears regulatory hurdles, Medtronic will be poised to advance its strategy of therapy
A revolutionary heart procedure is now being performed in the Valley. It's offering hope to patients who were once told, they were inoperable. A revolutionary heart procedure is now being performed in the Valley. It's offering hope to patients who
Medtronic Inc. said Thursday that the FDA approved its artificial heart valve, CoreValve, for use in more patients who face serious risks from open-heart surgery, the standard treatment. Medtronic's implant is a less invasive approach to replacing
Ironing is not exactly Barbara Roy's favorite activity, but it's something she's glad she can do again. "I'd probably iron a couple pieces and then have to come out here and sit down and rest," said Roy. Her doctor diagnosed her with severe aortic
Cerebral protection device developer Keystone Heart Ltd. has raised $14M in a Series B financing round led by OrbiMed. Keystone Hearts TriGuard is a cerebral protection device specifically designed to provide full coverage to all aortic arch takeoffs.
The George Hoag Family Advanced Hybrid Surgical Suite opened Wednesday...Michael Famularo, Director of Cardiology at French Hospital, says, "If you need an aortic valve, basically instead of having open heart surgery, and you need this valve, It
Patients who suffer from aortic stenosis have heart valves that do not fully open. The condition decreases blood flow from the heart, so doctors often recommend surgery to implant a prosthetic valve. CoreValve, a new minimally invasive system to
The device called the Medtronic CoreValve System, which has recently been approved by the Food and Drug Administration, is deployed with a catheter which is inserted in an artery in the groin and guided up to the heart to take over the function of a
Direct Flow Medical Inc., a developer of transcatheter aortic replacement valve systems, is expanding its headquarters in northwest Santa Rosa by 9,000 square feet to support additional staff as it embarks on key clinical trials toward full U.S.
A new study gives a big boost to fixing a bad aortic valve, the heart's main gate, without open-heart surgery. Survival rates were better one year later for people who had a new valve placed through a tube into an artery instead. The results were